Pricing Log in Create free account

Advanced Biomed Inc. (ADVB) vs ENDRA Life Sciences Inc. (NDRA)

Advanced Biomed Inc. and ENDRA Life Sciences Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. and ENDRA Life Sciences Inc. are of similar size ($8.1M and $7.7M). ENDRA Life Sciences Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.8×. Across the 9 metrics below, Advanced Biomed Inc. leads on 9 and ENDRA Life Sciences Inc. on 0.

Valuation

Metric ADVB NDRA Diagnostics & Research median
P/E 0.77 n/m 35.56
P/S n/m 17.54 4.37
P/B 0.41 0.99 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales n/m 2.22 5.51
Earnings yield 129.37% (133.33%) (1.89%)
Free cash flow yield (90.81%) (124.95%) (0.15%)

Profitability

Metric ADVB NDRA Diagnostics & Research median
Gross margin — 0.00% 50.89%
Operating margin 0.00% 0.00% (8.57%)
Net margin 0.00% 0.00% (6.37%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 84.77% (152.04%) (2.92%)
Return on assets 36.47% (110.08%) (6.71%)
Return on invested capital (33.43%) (539.89%) 0.00%

Growth

Metric ADVB NDRA Diagnostics & Research median
Revenue growth (TTM) — — 7.69%
EPS growth (last fiscal year) 266.53% 84.32% 25.92%
Revenue growth, 5-year CAGR — — 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB NDRA Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 9.33 7.10 2.02
Net debt to EBITDA 0.06 0.14 0.70

Dividend

Metric ADVB NDRA Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric ADVB NDRA Diagnostics & Research median
Market cap 8.06m 7.65m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack